While tirzepatide was on the shortage list, compounding pharmacies were able to legally make and sell the patent-protected drug in order to meet demand
In that backdrop, the judicious thing to do was to not over-commit and thats exactly what they did: didnt kill danuglipron, said its alive and may move forward. Pfizer said theyll move the pill to a mid-stage study in the second half of this year
Curcumol exhibits anti-inflammatory properties by interfering with the JNK-mediated AP-1 pathway in lipopolysaccharide-activated RAW264
Thymosin beta 4 is unusual in this compound class for having controlled human data, RGN-259 ophthalmic solution has been assessed in randomised, placebo-controlled, double-masked Phase 2 and Phase 3 trials in severe dry eye and neurotrophic keratopathy (Sosne et al., Cornea 2015 and Int J Mol Sci 2023)
He L, Wei Q, Liu J, Yi M, Liu Y, Liu H, et al